Listar por tema "glatiramer acetate"

Mostrando ítems 1-2 de 2

Biological and nonbiological complex drugs for multiple sclerosis in Latin America: Regulations and risk management

Carrá, A.; Macías Islas, M.A.; Tarulla, A.; Bichuetti, D.B.; Finkelsztejn, A.; Dadalti Fragoso, Y.; Árcega-Revilla, R.; Cárcamo Rodríguez, C.; Durán, J.C.; García Bonitto, J.; León, Rosalba; Oehninger Gatti, C.; Orozco, G.; Vizcarra-Escobar, Darwin (Taylor and Francis, 2015)

Biological drugs and nonbiological complex drugs with expired patents are followed by biosimilars and follow-on drugs that are supposedly similar and comparable with the reference product in terms of quality, safety and ...
Optimizing outcomes in multiple sclerosis: Consensus guidelines for the diagnosis and treatment of multiple sclerosis in Latin America

Carra, A.; Macías Islas, M.A.; Gabbai, A.A.; Correale, J.; Bolana, C.; Sotelo, E.D.; Bonitto, J.G.; Vergara Edwards, F.; Vizcarra-Escobar, Darwin (SAGE Publications, 2011)

Objective: The prevalence of multiple sclerosis (MS) in Latin America varies across different studies but an intermediate risk and increased frequency of the disease have been reported in recent years. The circumstances ...

Buscar en el Repositorio